• Home

  • About Rico

      About Rico
      • Company Profile

      • Development History

      • Corporate culture

      • Company environment

      • Company Honors

      About Rico
      营销与服务
      案例展示 留言咨询 联系我们
      业务咨询电话:
      0000-00000000
  • News

      News
      • Company News

      • Industry Trends

      News
      营销与服务
      案例展示 留言咨询 联系我们
      业务咨询电话:
      0000-00000000
  • Services

  • Cooperation

      Cooperation
      • Partner

      • Contact Us

      Cooperation
      营销与服务
      案例展示 留言咨询 联系我们
      业务咨询电话:
      0000-00000000
  • Policy

  • Join us

      Join us
      • Social Recruitment

      • Campus Recruitment

      Join us
      营销与服务
      案例展示 留言咨询 联系我们
      业务咨询电话:
      0000-00000000

CN

EN

Confirm
News Updates

Company News

Industry Trends

National policy

11-10

Image name

Rico International (Beijing) Medicine Technology Co., Ltd. was established in 2020.

Rico International (Beijing) Medicine Technology Co., Ltd. was established in 2020. It is composed of a group of accomplished and highly contributing pharmaceutical experts, scholars, and business management professionals in the pharmaceutical and healthcare fields. The company aims to assist domestic and international pharmaceutical enterprises in product introduction, technology acquisition, and market expansion; to bring global pharmaceutical and healthcare products and technologies into China, enabling Chinese consumers to access cutting-edge and high-quality medicines from around the world, thereby benefiting the Chinese people; and at the same time, to export Chinese pharmaceutical and healthcare products and technologies to overseas counterparts, benefiting all humanity.

Rico International (Beijing) Medicine Technology Co., Ltd. was established in 2020.

10-09

Image name

Announcement by the National Medical Products Administration on the Release of the Guiding Principles for Quality Agreements for Contract Manufacturing of Pharmaceuticals (2020 Edition) (No. 107 of 2020)

To implement the relevant provisions of the Drug Administration Law and further strengthen the supervision and management of drug production, the National Medical Products Administration has developed the “Guidelines for Quality Agreements on Contract Manufacturing of Drugs (2020 Edition),” which are intended to guide and supervise marketing authorization holders and contract manufacturing enterprises in fulfilling their obligations to ensure drug quality. These guidelines are hereby released and shall take effect from the date of their publication.

Announcement by the National Medical Products Administration on the Release of the Guiding Principles for Quality Agreements for Contract Manufacturing of Pharmaceuticals (2020 Edition) (No. 107 of 2020)

03-30

Image name

Drug Registration Management Measures

The “Administrative Measures for Drug Registration” were reviewed and approved at the 1st Bureau Meeting of the State Administration for Market Regulation on January 15, 2020, and are hereby promulgated and shall take effect as of July 1, 2020.

Drug Registration Management Measures

12-20

Image name

Notice of the National Medical Products Administration on the Issuance of Guiding Principles for Conditional Approval of Medical Devices for Market Launch (No. 93 of 2019)

To implement the "Opinions on Deepening the Reform of the Review and Approval System and Encouraging Innovation in Pharmaceuticals and Medical Devices" issued by the General Office of the CPC Central Committee and the General Office of the State Council, address clinical treatment needs for serious life-threatening diseases, and accelerate the review and approval process for relevant medical devices, the National Medical Products Administration has developed the Guiding Principles for Conditional Approval of Medical Devices for Market Launch (see attachment). These principles are hereby released.

Notice of the National Medical Products Administration on the Issuance of Guiding Principles for Conditional Approval of Medical Devices for Market Launch (No. 93 of 2019)

07-30

Image name

Regulations on the Management of Medical Device Instructions and Labels

The “Regulations on the Management of Instructions for Medical Devices and Labels” were reviewed and adopted at the Bureau Meeting of the State Administration for Food and Drug Administration on June 27, 2014. They are hereby promulgated and shall take effect as of October 1, 2014.

Regulations on the Management of Medical Device Instructions and Labels

07-30

Image name

Medical Device Registration and Management Measures

The “Administrative Measures for the Registration of Medical Devices” were reviewed and approved at the Bureau Meeting of the State Administration for Food and Drug Administration on June 27, 2014. They are hereby promulgated and shall take effect as of October 1, 2014.

Medical Device Registration and Management Measures
< 12345 >
  • Home

  • About Rico

    • Company Profile

    • Development History

    • Corporate culture

    • Company environment

    • Company Honors

  • News

    • Company News

    • Industry Trends

  • Services

  • Cooperation

    • Partner

    • Contact Us

  • Policy

  • Join us

    • Social Recruitment

    • Campus Recruitment

Rico International (Beijing) Medicine Technology Co., Ltd.

Tel: +86-10-53329998

Address: Room 905A, Building B, East Zone, Jianwai SOHO, No. 39, Middle Section of East Third Ring Road, Chaoyang District, Beijing

Facebook Linkedin Twitter Tumblr Pinterest

©2026 Rico International (Beijing) Medicine Technology Co., Ltd.  Powered by:CEglobal

Business license
中企跨境-全域组件 2.0.3 制作前进入CSS配置样式

导航下拉添加类名.active

在线客服添加返回顶部

右侧在线客服样式 1,2,3 4

图片alt标题设置: Rico International (Beijing) Medicine Technology Co., Ltd.

表单验证提示文本: Content cannot be empty!

循环体没有内容时: The materials are being organized—stay tuned!

CSS / JS 文件放置地